The case for & against
Bull & Bear analysis
Owlet, Inc. (NYSE: OWLT) is a leading innovator in health monitoring solutions primarily for infants, focusing on enhancing parental engagement and children's well-being through technology. The company is transitioning from a hardware-centric model to a subscription-based platform (Owlet360), aiming to establish ongoing relationships with families while leveraging pediatric health data to inform care and decision-making. This strategic shift positions Owlet favorably within the rising health tech landscape, particularly in the baby monitoring sector.
Bull says
- ↑Q2 2026 revenue reached $33.9 M, up 29.9% YoY
- ↑Owlet360 subscription attach of 30% with 130K subs and $3.2 M sub revenue
- ↑First FDA-cleared baby monitor offers regulatory moat
- ↑International revenue surged 214% YoY, driving global growth
- ↑New $25 M asset-based facility reduces borrowing costs, boosts liquidity
- ↑Strong growth and positive momentum factors support upside
Bear says
- ↓Earnings yield negative with weak profitability metrics
- ↓High leverage raises financial stability concerns amid rate hikes
- ↓Prime Day baby monitor sales down, signaling price pressure
- ↓Average subscriber life ~12 months limits recurring revenue visibility
- ↓Cautious consumer spending may curb discretionary monitor sales
- ↓Elevated volatility and negative quality factors increase risk
Earnings Call · Q1 2024 · Mgmt. Guidance
Transcript signals
Bull points
- We're starting off the year with strong double-digit revenue and sell-through growth, gross margin expansion, significant operating cost savings and adjusted EBITDA improvement over last year.
- In addition to our channel expansion, we're also focused on driving additional value to our customers through a new subscription service.
- In addition to our channel expansion, we're also focused on driving additional value to our customers through a new subscription service.